1,090.50
+0.5(+0.05%)
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
26015
First IPO Date
January 15, 1996
| Name | Title | Pay | Year Born |
| Dr. Makkapati Satakarni B.E., M.B.A., Ph.D. | President of Biologics, Chief Executive Officer of Biologics, Vaccines and Peptid & Director | 300,000 | 1981 |
| Mr. B. Adi Reddy | Compliance Officer & Company Secretary | 4.76M | N/A |
| Mr. Santhanam Subramanian | Chief Financial Officer | 21.06M | 1961 |
| Mr. Kambam Nithyananda Reddy | Vice Chairman & MD | 45.05M | 1958 |
| Mr. Mettu Madan Mohan Reddy | Whole-Time Director | 60.15M | 1960 |
| Dr. V. K. Handa | President of Chemical Research | 0 | 1952 |
| Mr. G. P. Prasad | Senior Vice President of Global Finance & Operations | 0 | N/A |
| Dr. S. Vijaya Kumar | President of Technical | 0 | 1966 |
| Dr. Sudhir Bimal Singhi | Head of Global Finance Operations | 0 | 1969 |
| Dr. A. Rama Mohana Rao | Chief Quality Officer -Corporate QA | 0 | 1962 |
Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients, generic pharmaceuticals, and related services in India. The company primarily offers oral solids, injectables, and over-the-counter drugs, as well as active pharmaceutical ingredients and finished dosage forms for cardiovascular, central nervous system, gastroenterology, anti-allergies, anti-diabetics, anti-retroviral, antibiotics, dermatology, respiratory, and oncology. It is also involved in the development of a product pipeline in biosimilar and vaccine segments; and custom research and manufacturing activities for the bio-tech and pharmaceutical community. In addition, the company develops and manufactures peptides, as well as biocatalysts for use in the pharmaceutical and chemical industries. Further, it is developing biosimilar, inhalers, transdermal patches, vaccines, topicals, and depot injections. The company also exports its products. It serves multinational companies. The company has an agreement with COVAXX to develop and commercialize COVID-19 Vaccine for India and UNICEF. Aurobindo Pharma Limited was incorporated in 1986 and is headquartered in Hyderabad, India.